Switching biologic drug class after resection for Crohn's disease association with increased risk of reintervention.

Saved in:
Bibliographic Details
Title: Switching biologic drug class after resection for Crohn's disease association with increased risk of reintervention.
Authors: Ziegler O; Department of Surgery, Penn State Hershey Medical Center, Hershey, PA, United States., Greene AC; Department of Surgery, Penn State Hershey Medical Center, Hershey, PA, United States., Schaefer EW; Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, United States., Deutsch MJ; Division of Colon and Rectal Surgery, Penn State Hershey Medical Center, Hershey, PA, United States., Scow JS; Division of Colon and Rectal Surgery, Penn State Hershey Medical Center, Hershey, PA, United States., Coates MD; Division of Gastroenterology and Hepatology, Department of Medicine, Penn State Hershey Medical Center, Hershey, PA, United States., Kulaylat AS; Division of Colon and Rectal Surgery, Penn State Hershey Medical Center, Hershey, PA, United States. Electronic address: akulaylat1@pennstatehealth.psu.edu.
Source: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract [J Gastrointest Surg] 2025 Jun; Vol. 29 (6), pp. 102033. Date of Electronic Publication: 2025 Mar 24.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9706084 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4626 (Electronic) Linking ISSN: 1091255X NLM ISO Abbreviation: J Gastrointest Surg Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1873-4626
DOI:10.1016/j.gassur.2025.102033